0.00
+0(+0.00%)
Currency In USD
Address
548 Market Street
San Francisco, CA 94104
United States of America
Phone
415 887 2311
Website
Sector
Healthcare
Industry
Biotechnology
Employees
54
First IPO Date
March 17, 2021
| Name | Title | Pay | Year Born |
| Mr. David P. Perry M.B.A. | Co-Founder & Executive Chairman | 110,667 | 1968 |
| Ms. Kristin Wynholds | Chief Product Officer | 390,000 | 1973 |
| Dr. Mark A. Berman M.D. | Chief Medical Officer | 425,000 | 1976 |
| Mr. Frank L. Karbe M.B.A. | Interim Chief Financial Officer | 500,000 | 1968 |
| Ms. Jessica Meng | Chief Commercial Officer | 0 | 1975 |
| Ms. Angela Willis | Senior Vice President of Market Access | 0 | N/A |
| Leslie Miller | Controller | 0 | N/A |
| Mr. Andres Camacho | Senior Vice President of Technology & Head of Engineering | 0 | N/A |
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
